Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Current Leases (2019 - 2025)

Editas Medicine (EDIT) has disclosed Current Leases for 7 consecutive years, with $6.1 million as the latest value for Q3 2025.

  • Quarterly Current Leases fell 62.86% to $6.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Sep 2025, down 62.86% year-over-year, with the annual reading at $14.7 million for FY2024, 20.45% up from the prior year.
  • Current Leases for Q3 2025 was $6.1 million at Editas Medicine, down from $6.1 million in the prior quarter.
  • The five-year high for Current Leases was $18.2 million in Q2 2024, with the low at $6.1 million in Q3 2025.
  • Average Current Leases over 5 years is $10.9 million, with a median of $10.3 million recorded in 2021.
  • The sharpest move saw Current Leases skyrocketed 76.03% in 2024, then crashed 66.2% in 2025.
  • Over 5 years, Current Leases stood at $10.3 million in 2021, then rose by 7.5% to $11.1 million in 2022, then grew by 9.76% to $12.2 million in 2023, then rose by 20.45% to $14.7 million in 2024, then plummeted by 58.45% to $6.1 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $6.1 million, $6.1 million, and $13.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.